NFKB1 and myeloid sarcoma: Western blot analysis showed that TSA pretreatment significantly prevented the enhancement effect of MS on the levels of nuclear NF-κB p65 protein 12 h after anesthesia in MS rats (Fig. 7a; t = 7.060, P < 0.001 DMSO versus TSA).